{"title":"APLAR 第 26 届亚太风湿病学协会联盟大会,2024 年 8 月 21-25 日。","authors":"","doi":"10.1111/1756-185X.15346","DOIUrl":null,"url":null,"abstract":"<p><span>Tey S.</span><sup>1</sup>; <span>Ahmad A.</span><sup>1</sup>; Samat S.<sup>1</sup>; Mohd Perdaus A.<sup>2</sup></p><p><sup>1</sup>KPJ Rawang Specialist Hospital; <sup>2</sup>KPJ Damansara Specialist Hospital</p><p><b>Background:</b> Retroperitoneal Fibrosis (RPF) is an interesting yet daunting rare clinical encounter, especially one that is associated with SLE. It was first described by Albarran in 1905, subsequently by Ormond in 1948, which involves the formation of fibrous bands around the abdominal aorta and its surrounding retroperitoneal organs. SLE coronary vasculitis is also another underappreciated entity, one that is occasionally encountered among young individuals in clinical practice, but not widely discussed in the literature till date.</p><p><b>Case Presentation:</b> We describe a young 38-year-old Malaysian female who was diagnosed with SLE and RPF after she presented with a 6-month history of a left lower quadrant abdominal pain and a worsening stable angina. She had undergone a recent coronary arterial bypass grafting (CABG) for a triple coronary arterial disease 1 year prior to this presentation. Her Computed Tomography Scan with Angiogram demonstrated periaortitis, RPF and a mural thrombus extending from the renal hilar region down to the common iliac arteries. Her CT coronary angiogram demonstrated microaneurysms and beadings. Her IgG4 level, cANCA and pANCA were negative. There were clinical and radiological improvements with intravenous (IV) Cyclophosphamide and high dose corticosteroids.</p><p><b>Conclusion:</b> Corticosteroids and immunosuppressants remain the preferred treatment modalities for RPF across case studies, with an optimistic prognosis. Relapses have been reported, especially ones that are associated with a positive anti-nuclear antigen (ANA) level. Therefore, patients should be educated and followed up closely.</p><p><b>Key Words</b>: SLE, Retroperitoneal Fibrosis, Coronary Vasculitis</p>","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"27 S3","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1756-185X.15346","citationCount":"0","resultStr":"{\"title\":\"Poster Abstracts Part B\",\"authors\":\"\",\"doi\":\"10.1111/1756-185X.15346\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><span>Tey S.</span><sup>1</sup>; <span>Ahmad A.</span><sup>1</sup>; Samat S.<sup>1</sup>; Mohd Perdaus A.<sup>2</sup></p><p><sup>1</sup>KPJ Rawang Specialist Hospital; <sup>2</sup>KPJ Damansara Specialist Hospital</p><p><b>Background:</b> Retroperitoneal Fibrosis (RPF) is an interesting yet daunting rare clinical encounter, especially one that is associated with SLE. It was first described by Albarran in 1905, subsequently by Ormond in 1948, which involves the formation of fibrous bands around the abdominal aorta and its surrounding retroperitoneal organs. SLE coronary vasculitis is also another underappreciated entity, one that is occasionally encountered among young individuals in clinical practice, but not widely discussed in the literature till date.</p><p><b>Case Presentation:</b> We describe a young 38-year-old Malaysian female who was diagnosed with SLE and RPF after she presented with a 6-month history of a left lower quadrant abdominal pain and a worsening stable angina. She had undergone a recent coronary arterial bypass grafting (CABG) for a triple coronary arterial disease 1 year prior to this presentation. Her Computed Tomography Scan with Angiogram demonstrated periaortitis, RPF and a mural thrombus extending from the renal hilar region down to the common iliac arteries. Her CT coronary angiogram demonstrated microaneurysms and beadings. Her IgG4 level, cANCA and pANCA were negative. There were clinical and radiological improvements with intravenous (IV) Cyclophosphamide and high dose corticosteroids.</p><p><b>Conclusion:</b> Corticosteroids and immunosuppressants remain the preferred treatment modalities for RPF across case studies, with an optimistic prognosis. Relapses have been reported, especially ones that are associated with a positive anti-nuclear antigen (ANA) level. Therefore, patients should be educated and followed up closely.</p><p><b>Key Words</b>: SLE, Retroperitoneal Fibrosis, Coronary Vasculitis</p>\",\"PeriodicalId\":14330,\"journal\":{\"name\":\"International Journal of Rheumatic Diseases\",\"volume\":\"27 S3\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1756-185X.15346\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Rheumatic Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.15346\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Rheumatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.15346","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
Tey S.1; Ahmad A.1; Samat S.1; Mohd Perdaus A.21KPJ Rawang 专科医院; 2KPJ Damansara 专科医院背景:腹膜后纤维化(RPF)是一种有趣而又令人生畏的罕见临床病,尤其是与系统性红斑狼疮相关的疾病。腹膜后纤维化最早由阿尔巴兰(Albarran)于1905年描述,随后由奥蒙德(Ormond)于1948年描述,它涉及腹主动脉及其周围腹膜后器官周围纤维带的形成。系统性红斑狼疮冠状血管炎也是另一种未被充分重视的疾病,在临床实践中偶尔会在年轻人中遇到,但迄今为止在文献中并未得到广泛讨论:我们描述了一名 38 岁的年轻马来西亚女性,她因 6 个月的左下腹痛和不断恶化的稳定型心绞痛病史而被诊断为系统性红斑狼疮和冠状动脉血管炎。一年前,她曾因三支冠状动脉疾病接受过冠状动脉旁路移植术(CABG)。她的计算机断层扫描和血管造影显示她患有大动脉周围炎、RPF 和壁状血栓,血栓从肾门区一直延伸到髂总动脉。她的 CT 冠状动脉造影显示出微动脉瘤和血珠。她的 IgG4 水平、cANCA 和 pANCA 均为阴性。静脉注射环磷酰胺和大剂量皮质类固醇后,她的临床和放射学状况均有所改善:结论:在所有病例研究中,皮质类固醇和免疫抑制剂仍是治疗 RPF 的首选方法,预后乐观。有复发的报道,尤其是与抗核抗原(ANA)阳性水平相关的复发。因此,应对患者进行教育和密切随访:系统性红斑狼疮 腹膜后纤维化 冠状动脉血管炎
Background: Retroperitoneal Fibrosis (RPF) is an interesting yet daunting rare clinical encounter, especially one that is associated with SLE. It was first described by Albarran in 1905, subsequently by Ormond in 1948, which involves the formation of fibrous bands around the abdominal aorta and its surrounding retroperitoneal organs. SLE coronary vasculitis is also another underappreciated entity, one that is occasionally encountered among young individuals in clinical practice, but not widely discussed in the literature till date.
Case Presentation: We describe a young 38-year-old Malaysian female who was diagnosed with SLE and RPF after she presented with a 6-month history of a left lower quadrant abdominal pain and a worsening stable angina. She had undergone a recent coronary arterial bypass grafting (CABG) for a triple coronary arterial disease 1 year prior to this presentation. Her Computed Tomography Scan with Angiogram demonstrated periaortitis, RPF and a mural thrombus extending from the renal hilar region down to the common iliac arteries. Her CT coronary angiogram demonstrated microaneurysms and beadings. Her IgG4 level, cANCA and pANCA were negative. There were clinical and radiological improvements with intravenous (IV) Cyclophosphamide and high dose corticosteroids.
Conclusion: Corticosteroids and immunosuppressants remain the preferred treatment modalities for RPF across case studies, with an optimistic prognosis. Relapses have been reported, especially ones that are associated with a positive anti-nuclear antigen (ANA) level. Therefore, patients should be educated and followed up closely.
期刊介绍:
The International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.